Upstream Bio · 3 hours ago
Regulatory CMC Manager
Upstream Bio is a public company based in Waltham, MA, focused on developing innovative treatments for severe asthma and chronic rhinosinusitis. The Regulatory CMC Manager will influence global regulatory strategies and ensure compliance with regulatory requirements throughout the product lifecycle.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Prepare, review, and submit high-quality CMC sections of regulatory documents including:
INDs/CTAs, BLAs/MAAs, supplements, and post-approval variations
Responses to health authority questions related to CMC topics
Contribute to the development of global CMC regulatory strategies and submission timelines in collaboration with internal colleagues and external CROs/CMOs for investigational and/or commercial products
Collaborate closely with Technical Operations and Quality teams to ensure regulatory requirements are met throughout product lifecycle
Perform regulatory assessment and guidance on product compliance topics including change controls, deviations, site inspections, and GMP investigations
Participate effectively on cross-functional teams and may serve as the primary regulatory CMC contact for assigned products and projects
Participate in regulatory agency meetings (e.g., FDA, EMA) preparation and support
Maintain awareness of global CMC regulatory requirements and trends; proactively assess impact to company products and processes
Qualification
Required
Bachelor's degree in Biology, Chemistry, Pharmacy or another related life-science field with 5–8 years of relevant experience in Regulatory Affairs or CMC within the biopharmaceutical industry
Solid understanding of CMC development for biologics
Proficiency in regulatory (FDA, EMA, Health Canada and ICH) guidelines
Experience in the preparation, including writing, of CMC modules (3.2.S / 3.2.P) of eCTD dossiers for early-phase IND/CTA and/or late-stage BLA/MAA submissions
Ability to collaborate and communicate in an open, clear, complete, timely and consistent manner
Strong sense of planning and prioritization and the ability to work with all levels of management
Preferred
Prior experience in medical devices and combination product development
Benefits
Health care
Vision
Dental
Retirement
PTO
Company
Upstream Bio
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. It is a sub-organization of Upstream Bio.
Funding
Current Stage
Public CompanyTotal Funding
$408MKey Investors
HBM Partners
2024-10-11IPO
2023-06-08Series B· $200M
2023-02-10Series A· $8M
Leadership Team
Recent News
2025-11-25
2025-11-07
2025-11-06
Company data provided by crunchbase